These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 29560779)
1. Ductal Carcinoma In Situ Simultaneously Involving the Breast and Epithelial Inclusions in an Ipsilateral Axillary Lymph Node. Commander LA; Ollila DW; O'Connor SM; Hertel JD; Calhoun BC Int J Surg Pathol; 2018 Sep; 26(6):564-568. PubMed ID: 29560779 [TBL] [Abstract][Full Text] [Related]
2. Synchronous ductal carcinoma in situ of the breast and within epithelial inclusions in an ipsilateral sentinel lymph node. Fitzpatrick-Swallow VL; Helin H; Cane P; Pinder SE Hum Pathol; 2013 Jan; 44(1):142-4. PubMed ID: 23089490 [TBL] [Abstract][Full Text] [Related]
3. Variations in the management of the axilla in screen-detected ductal carcinoma in situ: evidence from the UK NHS breast screening programme audit of screen detected DCIS. Nicholson S; Hanby A; Clements K; Kearins O; Lawrence G; Dodwell D; Bishop H; Thompson A; Eur J Surg Oncol; 2015 Jan; 41(1):86-93. PubMed ID: 25441934 [TBL] [Abstract][Full Text] [Related]
4. Ductal carcinoma in situ: value of sentinel lymph node biopsy. Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457 [TBL] [Abstract][Full Text] [Related]
5. The use of sentinel lymph node biopsy in the treatment of breast ductal carcinoma in situ: A Danish population-based study. Holm-Rasmussen EV; Jensen MB; Balslev E; Kroman N; Tvedskov TF Eur J Cancer; 2017 Dec; 87():1-9. PubMed ID: 29096155 [TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node biopsy is not necessary in patients diagnosed with ductal carcinoma in situ of the breast by stereotactic vacuum-assisted biopsy. Kotani H; Yoshimura A; Adachi Y; Ishiguro J; Hisada T; Ichikawa M; Gondou N; Hattori M; Kondou N; Sawaki M; Fujita T; Iwata H Breast Cancer; 2016 Mar; 23(2):190-4. PubMed ID: 24989112 [TBL] [Abstract][Full Text] [Related]
7. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ. Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180 [TBL] [Abstract][Full Text] [Related]
8. [The role of sentinel lymph node biopsy in breast cancer non-invading-duct]. Török K; Péley G; Mátrai Z; Bidlek M; Szabó E; Sinkovics I; Polgár C; Farkas E; Orosz Z; Köves I Magy Seb; 2006 Jun; 59(3):173-8. PubMed ID: 16937792 [TBL] [Abstract][Full Text] [Related]
9. [Evaluation of sentinel lymph node biopsy in detection of axillary lymph node metastasis in breast cancer]. Zhang JG; Zhong L; Li CL Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):235-6. PubMed ID: 17649646 [No Abstract] [Full Text] [Related]
10. [Ductal carcinoma in situ of the breast with microinvasion. Role of sentinel lymph node biopsy]. Le Bouëdec G; de Lapasse C; Mishellany F; Chêne G; Michy T; Gimbergues P; Dauplat J Gynecol Obstet Fertil; 2007 Apr; 35(4):317-22. PubMed ID: 17344087 [TBL] [Abstract][Full Text] [Related]
11. Sentinel node biopsy in ductal carcinoma in situ of the breast: Never justified? Sorrentino L; Sartani A; Bossi D; Amadori R; Nebuloni M; Truffi M; Bonzini M; Riggio E; Foschi D; Corsi F Breast J; 2018 May; 24(3):325-333. PubMed ID: 29024241 [TBL] [Abstract][Full Text] [Related]
12. A N0 Predicting Model for Sentinel Lymph Node Biopsy Omission in Early Breast Cancer Upstaged From Ductal Carcinoma in Situ. Yoo TK; Kim SJ; Lee J; Lee SB; Lee SJ; Park HY; Park HK; Chae BJ; Eom YH; Kim HS; Song BJ Clin Breast Cancer; 2020 Jun; 20(3):e281-e289. PubMed ID: 32147404 [TBL] [Abstract][Full Text] [Related]
13. Breast epithelial cells in dermal angiolymphatic spaces: a manifestation of benign mechanical transport. Diaz NM; Mayes JR; Vrcel V Hum Pathol; 2005 Mar; 36(3):310-3. PubMed ID: 15791577 [TBL] [Abstract][Full Text] [Related]
14. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy. Mittendorf EA; Arciero CA; Gutchell V; Hooke J; Shriver CD Curr Surg; 2005; 62(2):253-7. PubMed ID: 15796952 [TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion? Klauber-DeMore N; Tan LK; Liberman L; Kaptain S; Fey J; Borgen P; Heerdt A; Montgomery L; Paglia M; Petrek JA; Cody HS; Van Zee KJ Ann Surg Oncol; 2000 Oct; 7(9):636-42. PubMed ID: 11034239 [TBL] [Abstract][Full Text] [Related]
16. Predictors of invasion and axillary lymph node metastasis in patients with a core biopsy diagnosis of ductal carcinoma in situ: an analysis of 255 cases. Han JS; Molberg KH; Sarode V Breast J; 2011; 17(3):223-9. PubMed ID: 21545433 [TBL] [Abstract][Full Text] [Related]
17. The impact of sentinel lymph node biopsy in patients with a core biopsy diagnosis of ductal carcinoma in situ. Hung WK; Ying M; Chan M; Mak KL; Chan LK Breast Cancer; 2010 Oct; 17(4):276-80. PubMed ID: 19756924 [TBL] [Abstract][Full Text] [Related]
18. Metastatic "Ductal Carcinoma In Situ-Like" Lobular Carcinoma in a Lymph Node: A Case Report and Review of the Literature. Tijani S; Sharma K; Yuen H; Shaaban A Int J Surg Pathol; 2020 Jun; 28(4):436-439. PubMed ID: 31789065 [TBL] [Abstract][Full Text] [Related]
19. Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only. Dillon MF; McDermott EW; Quinn CM; O'Doherty A; O'Higgins N; Hill AD J Surg Oncol; 2006 Jun; 93(7):559-63. PubMed ID: 16705731 [TBL] [Abstract][Full Text] [Related]
20. Should axillary ultrasound be used in patients with a preoperative diagnosis of ductal carcinoma in situ? Ansari B; Boughey JC; Adamczyk DL; Degnim AC; Jakub JW; Morton MJ Am J Surg; 2012 Sep; 204(3):290-3. PubMed ID: 22749764 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]